Institutional & Family Asset Management, LLC Global Blood Therapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

  • $846 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 30, 2020
SELL
$52.76 - $74.49 $1,107 - $1,564
-21 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$48.73 - $81.82 $292 - $490
6 Added 40.0%
21 $1,000
Q3 2019

Nov 14, 2019
SELL
$45.35 - $57.91 $136 - $173
-3 Reduced 16.67%
15 $1,000
Q2 2019

Aug 14, 2019
BUY
$52.6 - $63.29 $946 - $1,139
18 New
18 $1,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email